OXULUMIS

Swiss trademark · 832057 · Word mark · In force

Register entry

Registration number
832057
Application number
05817/2025
Status
In force
Type
Word mark
Filed
Apr 22, 2025
Registered
Jun 13, 2025
Published
Jun 13, 2025
Protected until
Apr 22, 2035
Priority
05.03.2025 US
Language of procedure
French
Source
Swissreg

Goods and services

Pharmaceuticals

Préparations pharmaceutiques pour le traitement des maladies rétiniennes.

Medical devices

Dispositifs combinés d'administration de médicaments destinés au traitement des maladies rétiniennes.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 13, 2025

    Registered

    Published in Swissreg on 13.06.2025

Parties

Holder

Regeneron Pharmaceuticals, Inc.

777 Old Saw Mill River Road, Tarrytown, New York 10591, US

Agent

Bovard AG

BOVARD SA

Conseils en propriété intellectuelle Optingenstrasse 16, 3013 Berne

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.